2024 Q2 Form 10-Q Financial Statement

#000160706224000202 Filed on May 20, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $160.0K $136.0K
YoY Change 162.3% 56.32%
Cost Of Revenue $39.00K $61.00K
YoY Change -4.88% -15.28%
Gross Profit $121.0K $75.00K
YoY Change 505.0% 400.0%
Gross Profit Margin 75.63% 55.15%
Selling, General & Admin $191.0K $240.0K
YoY Change -2.55% 1.69%
% of Gross Profit 157.85% 320.0%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $191.0K $240.0K
YoY Change -2.55% 1.69%
Operating Profit -$70.00K -$165.0K
YoY Change -60.23% -25.34%
Interest Expense -$139.0K $143.0K
YoY Change 7.75% 14.4%
% of Operating Profit
Other Income/Expense, Net -$143.0K
YoY Change 14.4%
Pretax Income -$209.0K -$308.0K
YoY Change -31.48% -10.98%
Income Tax
% Of Pretax Income
Net Earnings -$209.0K -$308.0K
YoY Change -31.48% -10.98%
Net Earnings / Revenue -130.63% -226.47%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.01 -$0.01
COMMON SHARES
Basic Shares Outstanding 39.99M shares 39.99M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $118.0K $153.0K
YoY Change 93.44% 19.53%
Cash & Equivalents $0.00 $153.0K
Short-Term Investments
Other Short-Term Assets $6.000K $5.000K
YoY Change 0.0% 25.0%
Inventory
Prepaid Expenses $5.000K
Receivables $8.000K $10.00K
Other Receivables $0.00 $0.00
Total Short-Term Assets $132.0K $168.0K
YoY Change 78.38% 20.86%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $132.0K $168.0K
Total Long-Term Assets $0.00 $0.00
Total Assets $132.0K $168.0K
YoY Change 78.38% 20.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $268.0K $310.0K
YoY Change -7.27% 3.33%
Accrued Expenses $60.00K $66.00K
YoY Change 0.0% -8.33%
Deferred Revenue $29.00K $38.00K
YoY Change 0.0% -29.63%
Short-Term Debt $8.996M $8.799M
YoY Change 13.99% 15.4%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $9.462M $9.332M
YoY Change 12.79% 13.76%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $398.0K $355.0K
YoY Change 12.11% 17.94%
Total Long-Term Liabilities $398.0K $355.0K
YoY Change 12.11% 17.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.462M $9.332M
Total Long-Term Liabilities $398.0K $355.0K
Total Liabilities $9.860M $9.687M
YoY Change 12.76% 13.91%
SHAREHOLDERS EQUITY
Retained Earnings -$28.28M -$28.08M
YoY Change 3.89% 4.29%
Common Stock $400.0K $400.0K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$9.728M -$9.519M
YoY Change
Total Liabilities & Shareholders Equity $132.0K $168.0K
YoY Change 78.38% 20.86%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$209.0K -$308.0K
YoY Change -31.48% -10.98%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$93.00K -$102.0K
YoY Change -54.85% -42.05%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 58.00K 196.0K
YoY Change -58.27% 61.98%
NET CHANGE
Cash From Operating Activities -93.00K -102.0K
Cash From Investing Activities
Cash From Financing Activities 58.00K 196.0K
Net Change In Cash -35.00K 94.00K
YoY Change -47.76% -270.91%
FREE CASH FLOW
Cash From Operating Activities -$93.00K -$102.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000773318
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-15113
dei Entity Registrant Name
EntityRegistrantName
VERITEC, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
95-3954373
dei Entity Address Address Line1
EntityAddressAddressLine1
2445 Winnetka Avenue N.
dei Entity Address City Or Town
EntityAddressCityOrTown
Golden Valley
dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55427
dei City Area Code
CityAreaCode
(763)
dei Local Phone Number
LocalPhoneNumber
253-2670
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
VRTC
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
39988007 shares
CY2024Q1 us-gaap Cash
Cash
153000 usd
CY2023Q2 us-gaap Cash
Cash
61000 usd
CY2024Q1 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
10000 usd
CY2023Q2 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
7000 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5000 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
168000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
74000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
310000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
289000 usd
CY2024Q1 VRTC Accounts Payable Related Parties
AccountsPayableRelatedParties
119000 usd
CY2023Q2 VRTC Accounts Payable Related Parties
AccountsPayableRelatedParties
119000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
66000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
60000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
38000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
29000 usd
CY2024Q1 VRTC Convertible Notes And Notes Payable In Default
ConvertibleNotesAndNotesPayableInDefault
539000 usd
CY2023Q2 VRTC Convertible Notes And Notes Payable In Default
ConvertibleNotesAndNotesPayableInDefault
525000 usd
CY2024Q1 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
586000 usd
CY2023Q2 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
570000 usd
CY2024Q1 VRTC Convertible Notes And Notes Payable Related Party In Default
ConvertibleNotesAndNotesPayableRelatedPartyInDefault
249000 usd
CY2023Q2 VRTC Convertible Notes And Notes Payable Related Party In Default
ConvertibleNotesAndNotesPayableRelatedPartyInDefault
242000 usd
CY2024Q1 VRTC Notes Payable Related Parties Current
NotesPayableRelatedPartiesCurrent
8213000 usd
CY2023Q2 VRTC Notes Payable Related Parties Current
NotesPayableRelatedPartiesCurrent
7322000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
9332000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
8389000 usd
CY2024Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
200000 usd
CY2023Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
200000 usd
CY2024Q1 VRTC Contingent Earnout Liability
ContingentEarnoutLiability
155000 usd
CY2023Q2 VRTC Contingent Earnout Liability
ContingentEarnoutLiability
155000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
9687000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
8744000 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39988007 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39988007 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
400000 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
400000 usd
CY2024Q1 VRTC Common Stock To Be Issued
CommonStockToBeIssued
12000 usd
CY2023Q2 VRTC Common Stock To Be Issued
CommonStockToBeIssued
12000 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18143000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18143000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-28075000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27226000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-9519000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-8670000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
168000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
74000 usd
CY2024Q1 VRTC Mobile Banking Technology Revenue
MobileBankingTechnologyRevenue
44000 usd
CY2023Q1 VRTC Mobile Banking Technology Revenue
MobileBankingTechnologyRevenue
33000 usd
VRTC Mobile Banking Technology Revenue
MobileBankingTechnologyRevenue
118000 usd
VRTC Mobile Banking Technology Revenue
MobileBankingTechnologyRevenue
123000 usd
CY2024Q1 VRTC Revenue Related Parties
RevenueRelatedParties
92000 usd
CY2023Q1 VRTC Revenue Related Parties
RevenueRelatedParties
54000 usd
VRTC Revenue Related Parties
RevenueRelatedParties
183000 usd
VRTC Revenue Related Parties
RevenueRelatedParties
172000 usd
CY2024Q1 us-gaap Revenues
Revenues
136000 usd
CY2023Q1 us-gaap Revenues
Revenues
87000 usd
us-gaap Revenues
Revenues
301000 usd
us-gaap Revenues
Revenues
295000 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
61000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
72000 usd
us-gaap Cost Of Revenue
CostOfRevenue
134000 usd
us-gaap Cost Of Revenue
CostOfRevenue
170000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
240000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
236000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
605000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
687000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
301000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
308000 usd
us-gaap Costs And Expenses
CostsAndExpenses
739000 usd
us-gaap Costs And Expenses
CostsAndExpenses
857000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-165000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-221000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-438000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-562000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
143000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
125000 usd
us-gaap Interest Expense
InterestExpense
411000 usd
us-gaap Interest Expense
InterestExpense
367000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-143000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-125000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-411000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-367000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-308000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-346000 usd
us-gaap Net Income Loss
NetIncomeLoss
-849000 usd
us-gaap Net Income Loss
NetIncomeLoss
-929000 usd
CY2024Q1 VRTC Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.01
CY2023Q1 VRTC Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.01
VRTC Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.02
VRTC Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.02
CY2024Q1 VRTC Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
39988007 shares
CY2023Q1 VRTC Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
39988007 shares
VRTC Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
39988007 shares
VRTC Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
39988007 shares
CY2024Q1 VRTC Selling General And Administrative Expense Related Party
SellingGeneralAndAdministrativeExpenseRelatedParty
13000 usd
CY2023Q1 VRTC Selling General And Administrative Expense Related Party
SellingGeneralAndAdministrativeExpenseRelatedParty
12000 usd
VRTC Selling General And Administrative Expense Related Party
SellingGeneralAndAdministrativeExpenseRelatedParty
39000 usd
VRTC Selling General And Administrative Expense Related Party
SellingGeneralAndAdministrativeExpenseRelatedParty
38000 usd
CY2024Q1 VRTC Interest And Debt Expense Related Party
InterestAndDebtExpenseRelatedParty
140000 usd
CY2023Q1 VRTC Interest And Debt Expense Related Party
InterestAndDebtExpenseRelatedParty
120000 usd
VRTC Interest And Debt Expense Related Party
InterestAndDebtExpenseRelatedParty
396000 usd
VRTC Interest And Debt Expense Related Party
InterestAndDebtExpenseRelatedParty
352000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-9211000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-308000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-9519000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-8670000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-849000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-9519000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-8019000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-346000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-8365000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-7436000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-929000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-8365000 usd
us-gaap Net Income Loss
NetIncomeLoss
-849000 usd
us-gaap Net Income Loss
NetIncomeLoss
-929000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
412000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
367000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
9000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
29000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
189000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
21000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
29000 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
7000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
6000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
13000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-403000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-293000 usd
us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
528000 usd
us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
355000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
33000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
495000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
355000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
92000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
62000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
61000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
153000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
128000 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Net Income Loss
NetIncomeLoss
-849000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-403000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-9519000 usd
CY2024Q1 VRTC Notes Payable In Default
NotesPayableInDefault
788000 usd
CY2023Q2 VRTC Notes Payable In Default No Relation
NotesPayableInDefaultNoRelation
475000 usd
CY2024Q1 us-gaap Notes Payable
NotesPayable
30000 usd
CY2023Q2 us-gaap Notes Payable
NotesPayable
29000 usd
CY2024Q1 us-gaap Notes And Loans Payable
NotesAndLoansPayable
586000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84B_eus-gaap--UseOfEstimates_zuN2gALBU8eD" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_86A_zGzYiLq7S1Vb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Estimates</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Those estimates and assumptions include estimates for reserves of uncollectible accounts, accruals for potential liabilities, assumptions made in valuing stock instruments issued for services, and valuation of deferred tax assets. Actual results could differ from those estimates.</p>
us-gaap Revenue Recognition Leases Operating
RevenueRecognitionLeasesOperating
<p id="xdx_84D_eus-gaap--RevenueRecognitionLeasesOperating_zCXHDw8NGkSY" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_862_zfXKzGhXx9cF" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue Recognition</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues for the Company are classified into management fee revenue and mobile banking technology.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASC 606"). The underlying principle of ASC 606 is to recognize revenue to depict the transfer of goods or services to customers at the amount expected to be collected. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contracts, which includes (1) identifying the contracts or agreements with a customer, (2) identifying the Company’s performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the services it transfers to its clients.</span></p> <p style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Mobile Banking Technology Revenue</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company, as a merchant payment processor and a distributor, recognizes revenue from transaction fees charged to cardholders for the use of its issued mobile debit cards. The fees are recognized on a monthly basis after all cardholder transactions have been summarized and reconciled with third party processors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Other Revenue, Management Fee – Related Party</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 30, 2015, the Company sold all of its assets of its Barcode Technology, which was comprised solely of its intellectual property, to The Matthews Group (a related party, see Note 6). The Company subsequently entered into a management services agreement with The Matthews Group to manage all facets of the barcode technology operations through June 30, 2024. The Company earned a fee of 35% of all revenues billed up to March 31, 2024. The Company recognizes management fee revenue as services are performed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Disaggregation of Net Sales</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table shows the Company’s disaggregated net sales by customer type for the three and nine months ended March 31, 2024 and 2023:</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></p> <table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfDisaggregatedNetSalesByCustomerTableTextBlock_zI2HkMuxQtTE" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Summary of Disaggregated Net Sales (Details)"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; vertical-align: top; text-align: left"><span id="xdx_8BF_zdGAva5ysMy5" style="color: White">Disaggregate Net Sales</span></td> <td style="font-weight: bold; text-align: center"> </td> <td style="font-weight: bold; text-align: center"> </td> <td id="xdx_490_20240101__20240331_zBY97fNZqW8_zYsNL9zD9Ga4" style="font-weight: bold; text-align: center"> </td> <td style="font-weight: bold; text-align: center"> </td> <td style="font-weight: bold; text-align: center"> </td> <td style="font-weight: bold; text-align: center"> </td> <td id="xdx_493_20230101__20230331_zmE9eqyphGwV" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="font-weight: bold; text-align: center"> </td> <td style="font-weight: bold; text-align: center"> </td> <td id="xdx_498_20230701__20240331_zJqFARNtVbwd" style="font-weight: bold; text-align: center"> </td> <td style="font-weight: bold; text-align: center"> </td> <td style="font-weight: bold; text-align: center"> </td> <td style="font-weight: bold; text-align: center"> </td> <td id="xdx_492_20220701__20230331_zeE2co0XhLGd" style="font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Nine Months Ended</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td></tr> <tr id="xdx_40F_eus-gaap--RevenuesNetOfInterestExpense_hsrt--ProductOrServiceAxis__custom--MedicalMember_z941dnUCldXP" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">Medical</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">35,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">12,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">89,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">34,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenuesNetOfInterestExpense_hsrt--ProductOrServiceAxis__us-gaap--BankingMember_zT6emOcZZ7gf" style="vertical-align: bottom; background-color: White"> <td>Banking</td><td> </td> <td style="text-align: left"></td><td style="text-align: right">3,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">`</td><td style="text-align: right">15,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"></td><td style="text-align: right">11,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"></td><td style="text-align: right">71,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--RevenuesNetOfInterestExpense_hsrt--ProductOrServiceAxis__custom--AssociationsMember_zlReW8Y3dmYm" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Associations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--RevenuesNetOfInterestExpense_hsrt--ProductOrServiceAxis__custom--EducationMember_zOsF2AyNJ8mM" style="vertical-align: bottom; background-color: White"> <td>Education</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--RevenuesNetOfInterestExpense_hsrt--ProductOrServiceAxis__custom--OtherMember_zqvKCLm9u0so" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Other revenue, management fee related party</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">92,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">54,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">183,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">172,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--RevenuesNetOfInterestExpense_zQuUoHzoIdKY" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">136,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">87,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">301,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">295,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AD_zMJz9ceTSLG7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">During the nine months ended March 31, 2024 and 2023, all of the Company’s Mobile banking technology revenues were earned in the United States of America. </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Other revenue, management fee - related party revenue was $<span id="xdx_90D_ecustom--RevenueRelatedParties_pp0p0_c20240101__20240331_zH1580lhBNmb">92,000 </span>and $<span id="xdx_90A_ecustom--RevenueRelatedParties_pp0p0_c20230701__20240331_zLrjajWQK4Kg">183,000</span>, and $<span id="xdx_907_ecustom--RevenueRelatedParties_pp0p0_c20230101__20230331_zsRZ093XBw1O">54,000 </span>and $<span id="xdx_90E_ecustom--RevenueRelatedParties_pp0p0_c20220701__20230331_zYIXIoTC6n5R">172,000</span>, for the three and nine months ended March 31, 2024 and 2023, respectively, and realized from our management services agreement with The Matthews Group, a related party, which requires us to manage The Matthews Group’s barcode technology operations. The Matthews Group’s barcode technology customers are primarily manufacturing companies located in China.</p>
CY2024Q1 us-gaap Revenues Net Of Interest Expense
RevenuesNetOfInterestExpense
136000 usd
CY2023Q1 us-gaap Revenues Net Of Interest Expense
RevenuesNetOfInterestExpense
87000 usd
us-gaap Revenues Net Of Interest Expense
RevenuesNetOfInterestExpense
301000 usd
us-gaap Revenues Net Of Interest Expense
RevenuesNetOfInterestExpense
295000 usd
CY2024Q1 VRTC Revenue Related Parties
RevenueRelatedParties
92000 usd
VRTC Revenue Related Parties
RevenueRelatedParties
183000 usd
CY2023Q1 VRTC Revenue Related Parties
RevenueRelatedParties
54000 usd
VRTC Revenue Related Parties
RevenueRelatedParties
172000 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
32621388 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
27737207 shares
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_zlQdOb0Vdij_zxcSlZF8NeNk" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_866_zgTxOOqryfbF" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concentrations</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">During the three months ended March 31, 2024, the Company had one customer that represented <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SalesRevenueSegmentMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zEjsqpIskKns">68</span>% (related party) of our revenues, and one customer that represented <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SalesRevenueSegmentMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zNvqeNmtUaGc">26</span>% of our revenues. During the three months ended March 31, 2023, the Company had three major customers, one that represented <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SalesRevenueSegmentMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zZMDzXsxpAeK">14</span>% of our revenue, one that represented <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SalesRevenueSegmentMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zAWzu8C0deS_zH1abopawSra">12</span>% of our revenue, and one, a related party, that represented <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SalesRevenueSegmentMember__srt--MajorCustomersAxis__custom--CustomerRelatedPartyMember_zQJBQeuLerBu">62</span>% of our revenue.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">No other customer represented more than 10% of our revenues.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">During the nine months ended March 31, 2024, the Company had one customer that represented <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SalesRevenueSegmentMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zuT6KFuhpkdF">61</span>% (related party) of our revenues, and one customer that represented <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SalesRevenueSegmentMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zwbisxmemk3m">30</span>% of our revenues. <span style="background-color: white">During the six months ended March 31, 2023, the Company had three major customers, one that represented <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SalesRevenueSegmentMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zmmH2FCvQ16V">24</span></span><span style="background-color: white">% of our revenue, one that represented <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SalesRevenueSegmentMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zkHLuAddDFGt">13</span></span><span style="background-color: white">% of our revenue, and one, a related party, that represented <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SalesRevenueSegmentMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zXTpmQ1VQ4v_z0JchuMNOMfI">57</span></span><span style="background-color: white">% of our revenues.</span> No other customer represented more than 10% of our revenues.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">At March 31, 2024 and June 30, 2023, one customer represented substantially all of the Company’s accounts receivable balance as of that date.</p>
CY2024Q1 VRTC Convertible Notes Payable In Default
ConvertibleNotesPayableInDefault
68000 usd
CY2023Q2 VRTC Convertible Notes Payable In Default
ConvertibleNotesPayableInDefault
66000 usd
CY2024Q1 VRTC Notes Payable In Default No Relation
NotesPayableInDefaultNoRelation
488000 usd
CY2023Q2 us-gaap Notes And Loans Payable
NotesAndLoansPayable
570000 usd
CY2024Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.08
CY2023Q2 us-gaap Notes Payable
NotesPayable
29000 usd
CY2024Q1 us-gaap Notes Payable
NotesPayable
30000 usd
CY2024Q1 VRTC Notes Payable Related Parties
NotesPayableRelatedParties
8213000 usd
CY2023Q2 VRTC Notes Payable Related Parties
NotesPayableRelatedParties
7322000 usd
us-gaap Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
145000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
33000 usd
CY2024Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
494000 usd
CY2024Q1 VRTC Convertible Notes And Notes Payable Related Party In Default
ConvertibleNotesAndNotesPayableRelatedPartyInDefault
249000 usd
CY2024Q1 VRTC Notes Payable Due On Demand
NotesPayableDueOnDemand
245000 usd
CY2023Q2 VRTC Common Stock To Be Issued Shares
CommonStockToBeIssuedShares
145000 shares
CY2023Q2 VRTC Common Stock To Be Issued
CommonStockToBeIssued
12000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
900000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.03
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
350000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.03
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
550000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.03
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
550000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.03
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 usd
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.03
VRTC Managament Fee Percent Of Revenue
ManagamentFeePercentOfRevenue
0.35 pure
CY2024Q1 VRTC Fee Revenue
FeeRevenue
92000 usd
CY2023Q1 VRTC Fee Revenue
FeeRevenue
183000 usd
VRTC Fee Revenue
FeeRevenue
54000 usd
VRTC Fee Revenue
FeeRevenue
175000 usd
VRTC Agreements With Nugen
AgreementsWithNugen
<p id="xdx_803_ecustom--AgreementsWithNugen_zkFS2dGBwCTO" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><b>NOTE 7 – <span id="xdx_82F_zl3xzagJr5IJ">AGREEMENTS WITH NUGEN</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; background-color: white">On July 4, 2022, the Company entered a Memorandum of Understanding (the “MOU”) for the purpose of forming a strategic partnership between the Company and Nugen Universe, LLC (“Nugen”), a corporation located in Wrightsville Beach, North Carolina. Nugen seeks the Company to modify, create, or build a “private label” system for Nugen, with an initial interest in the Company’s blinxPay technology and Bio-ID verification system. Nugen paid the Company $<span id="xdx_90B_eus-gaap--RevenuesNetOfInterestExpense_c20230101__20230331__srt--ProductOrServiceAxis__custom--MOUBankingMember_ztjbM27M3won">50,000</span> at the date of the MOU signing and during the period ended March 31, 2023, the Company completed its performance obligations, and recorded the $50,000 payment as Mobile banking technology revenue during the period then ended. Nugen further agreed to pay the Company a 5% ongoing royalty for licensing the Company’s blinxPay technology and Bio-ID verification system. As of March 31, 2024, no royalties have been realized under the MOU.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; background-color: white">On October 10, 2022, the Company entered into a License and Distributor Agreement (“License Agreement”) with Nugen. The License Agreement became effective on receipt of $<span id="xdx_90A_eus-gaap--DeferredRevenueNoncurrent_iI_c20240331_z6QcjgLMZDQS">200,000</span> in December 2022 and extends through August 31, 2027. The License Agreement grants Nugen a Worldwide license and distribution for the Company’s blinxPay Close-Loop Virtual Wallet and blinxPay Open-Loop Visa Debit and all hardware products of the Company. Per the terms of the License Agreement, Nugen agrees to pay the Company a one-time license payment of $1,000,000 for the right to market the Company’s products noted above, of which $<span id="xdx_901_eus-gaap--DeferredRevenueNoncurrent_iI_c20240331_zkqP5tFUKrYm">200,000</span> was received by the Company in December 2022. The initial $<span id="xdx_908_eus-gaap--DeferredRevenueNoncurrent_iI_c20240331_zl21Ul1seNQ5">200,000</span> has been recorded as deferred revenue in the Consolidated Balance Sheet. The deferred revenue balance of $<span id="xdx_902_eus-gaap--DeferredRevenueNoncurrent_iI_c20240331_zU73zTyyMu8F">200,000 </span>at March 31, 2024, will begin being amortized to Mobile banking technology revenue starting once the Company has met its performance obligations under the License Agreement through the remaining term of the License Agreement, which expires on August 31, 2027. The remaining balance of $800,000 is scheduled to be paid as follows: $100,000 when the Company’s identifies a domestic sponsor bank, $350,000 to integrate the Company’s blinxPay software platform, and interface blinxPay with a sponsor foreign bank, and $350,000 on the completion of the final stage of testing, installation, and launch. In addition to the one-time license payment, Nugen agrees to pay a minimum monthly support fee plus 5% royalty from all sales of products noted above. As of March 31, 2024, no royalty related revenues have been realized under the License Agreement.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
200000 usd
CY2024Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
200000 usd
CY2024Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
200000 usd
CY2024Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
200000 usd
CY2016Q3 VRTC Convertible Note Payable Relinquished
ConvertibleNotePayableRelinquished
365000 usd
CY2016Q3 VRTC Shares To Be Returned
SharesToBeReturned
500000 shares
CY2022Q2 VRTC Program Setup Fee
ProgramSetupFee
10000 usd
CY2021Q4 VRTC Sales Commissions
SalesCommissions
0.15 pure
CY2021Q4 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
500000 shares
CY2021Q4 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
2000000 usd
CY2008Q4 VRTC Incentive Compensation Plan Percentage
IncentiveCompensationPlanPercentage
0.10 pure
CY2008Q4 VRTC Incentive Compensation Bonus Minimum Threshold
IncentiveCompensationBonusMinimumThreshold
3000000 usd
CY2008Q4 us-gaap Termination Loans
TerminationLoans
1000000 usd
us-gaap Payments To Employees
PaymentsToEmployees
75000 usd
us-gaap Payments To Employees
PaymentsToEmployees
75000 usd
CY2024Q2 us-gaap Customer Advances Current
CustomerAdvancesCurrent
150000 usd
CY2024Q3 us-gaap Customer Advances Current
CustomerAdvancesCurrent
50000 usd
VRTC Minimum Revenue Guarantee
MinimumRevenueGuarantee
60000 usd
VRTC Minimum Revenue Guarantee
MinimumRevenueGuarantee
120000 usd
VRTC Minimum Revenue Guarantee
MinimumRevenueGuarantee
180000 usd

Files In Submission

Name View Source Status
0001607062-24-000202-index-headers.html Edgar Link pending
0001607062-24-000202-index.html Edgar Link pending
0001607062-24-000202.txt Edgar Link pending
0001607062-24-000202-xbrl.zip Edgar Link pending
ex31_1.htm Edgar Link pending
ex32_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vrtc-20240331.xsd Edgar Link pending
vrtc-20240331_def.xml Edgar Link unprocessable
vrtc-20240331_lab.xml Edgar Link unprocessable
vrtc-20240331_pre.xml Edgar Link unprocessable
vrtc033124form10q.htm Edgar Link pending
vrtc033124form10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
vrtc-20240331_cal.xml Edgar Link unprocessable